Cancers | Feature Papers from the First Half of 2024 in the Section “Cancer Biomarkers”
As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2024 in the Section “Cancer Biomarkers”, which are listed below:
1. “Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-Analysis”
by Taha Koray Sahin, Alessandro Rizzo, Sercan Aksoy and Deniz Can Guven
Cancers 2024, 16(10), 1835; https://doi.org/10.3390/cancers16101835
Available online: https://www.mdpi.com/2072-6694/16/10/1835
2. “Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma”
by Lena Nanz, Ulrike Keim, Alexander Katalinic, Thomas Meyer, Claus Garbe and Ulrike Leiter
Cancers 2024, 16(3), 606; https://doi.org/10.3390/cancers16030606
Available online: https://www.mdpi.com/2072-6694/16/3/606
3. “Exosomes in Glioma: Unraveling Their Roles in Progression, Diagnosis, and Therapy”
by Song Yang, Yumeng Sun, Wei Liu, Yi Zhang, Guozhu Sun, Bai Xiang and Jiankai Yang
Cancers 2024, 16(4), 823; https://doi.org/10.3390/cancers16040823
Available online: https://www.mdpi.com/2072-6694/16/4/823
4. “Cuproptosis: Unraveling the Mechanisms of Copper-Induced Cell Death and Its Implication in Cancer Therapy”
by Chloe Springer, Danish Humayun and Rachid Skouta
Cancers 2024, 16(3), 647; https://doi.org/10.3390/cancers16030647
Available online: https://www.mdpi.com/2072-6694/16/3/647
5. “Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know?”
by Maria Cecília Mathias-Machado, Victor Hugo Fonseca de Jesus, Alexandre Jácome, Mauro Daniel Donadio, Marcelo Porfirio Sunagua Aruquipa, João Fogacci, Renato Guerino Cunha, Leonard Medeiros da Silva and Renata D’Alpino Peixoto
Cancers 2024, 16(3), 679; https://doi.org/10.3390/cancers16030679
Available online: https://www.mdpi.com/2072-6694/16/3/679
6. “PIK Your Poison: The Effects of Combining PI3K and CDK Inhibitors against Metastatic Cutaneous Squamous Cell Carcinoma In Vitro”
by Jay R. Perry, Benjamin Genenger, Amarinder Singh Thind, Bruce Ashford, and Marie Ranson
Cancers 2024, 16(2), 370; https://doi.org/10.3390/cancers16020370
Available online: https://www.mdpi.com/2072-6694/16/2/370
7. “The Emerging Role of Tertiary Lymphoid Structures in Breast Cancer: A Narrative Review”
by Dana Narvaez, Jorge Nadal, Adrian Nervo, María Victoria Costanzo, Claudio Paletta, Fernando E. Petracci, Sergio Rivero, Alexis Ostinelli, Berenice Freile, Diego Enrico et al.
Cancers 2024, 16(2), 396; https://doi.org/10.3390/cancers16020396
Available online: https://www.mdpi.com/2072-6694/16/2/396
8. “Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response”
by Clara Vianello, Elisa Monti, Ilaria Leoni, Giuseppe Galvani, Catia Giovannini, Fabio Piscaglia, Claudio Stefanelli, Laura Gramantieri and Francesca Fornari
Cancers 2024, 16(4), 766; https://doi.org/10.3390/cancers16040766
Available online: https://www.mdpi.com/2072-6694/16/4/766
9. “The Detection and Negative Reversion of Circulating Tumor Cells as Prognostic Biomarkers for Metastatic Castration-Resistant Prostate Cancer with Bone Metastases Treated by Enzalutamide”
by So Nakamura, Masayoshi Nagata, Naoya Nagaya, Takeshi Ashizawa, Hisashi Hirano, Yan Lu, Hisamitsu Ide and Shigeo Horie
Cancers 2024, 16(4), 772; https://doi.org/10.3390/cancers16040772
Available online: https://www.mdpi.com/2072-6694/16/4/772
10. “Supplement Use and Increased Risks of Cancer: Unveiling the Other Side of the Coin”
by Parnian Jabbari, Omid Yazdanpanah, David J. Benjamin and Arash Rezazadeh Kalebasty
Cancers 2024, 16(5), 880; https://doi.org/10.3390/cancers16050880
Available online: https://www.mdpi.com/2072-6694/16/5/880
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office